Direct Rx is recalling 17 bottles of Nortriptyline HCL (10 mg) capsules, a prescription medication used to treat depression. The recall was initiated because the active ingredient used in this specific batch was sourced from an alternate supplier and used before the manufacturing site had formally qualified that supplier for use. This deviation from Current Good Manufacturing Practice (cGMP) standards means the quality and consistency of the ingredient were not fully verified prior to production.
Using an unverified active ingredient can lead to inconsistent drug potency or the presence of unexpected impurities, which may reduce the medication's effectiveness or cause unforeseen side effects.
Healthcare consultation and pharmacy refund
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.